Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001288123-15-000006
Filing Date
2015-02-17
Accepted
2015-02-17 18:03:55
Documents
1
Period of Report
2015-02-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4321
  Complete submission text file 0001288123-15-000006.txt   5759
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Issuer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421
Business Address
Baysal Ozer (Reporting) CIK: 0001579446 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 15624847